Short Interest in Straumann Holding AG (OTCMKTS:SAUHY) Drops By 77.6%

Straumann Holding AG (OTCMKTS:SAUHY) was the recipient of a large decrease in short interest during the month of July. As of July 31st, there was short interest totaling 5,152 shares, a decrease of 77.6% from the July 15th total of 23,021 shares. Based on an average trading volume of 79,441 shares, the days-to-cover ratio is currently 0.1 days. Approximately 0.0% of the shares of the stock are short sold.

Wall Street Analyst Weigh In

SAUHY has been the topic of a number of recent research reports. Morgan Stanley reiterated an “underweight” rating on shares of Straumann in a research report on Tuesday, June 30th. Citigroup reaffirmed a “sell” rating on shares of Straumann in a research note on Thursday, July 9th. Barclays restated an “overweight” rating on shares of Straumann in a report on Thursday, June 18th. Deutsche Bank Aktiengesellschaft reissued a “buy” rating on shares of Straumann in a research note on Tuesday, June 30th. Finally, BMO Capital Markets started coverage on shares of Straumann in a report on Wednesday, July 8th. They set an “outperform” rating for the company. Three investment analysts have rated the stock with a Buy rating, two have assigned a Hold rating and two have assigned a Sell rating to the stock. According to data from MarketBeat.com, the company presently has a consensus rating of “Hold”.

Straumann Price Performance

Shares of SAUHY stock opened at $12.55 on Friday. Straumann has a 12 month low of $9.44 and a 12 month high of $13.61. The company’s fifty day simple moving average is $12.56 and its 200-day simple moving average is $11.71.

Straumann Company Profile

Straumann (OTCMKTS:SAUHY) is a Swiss-based dental technology company that develops, manufactures and markets restorative, regenerative and digital solutions for dental professionals. The company’s core offerings center on implant-supported restorations and components, biomaterials used for bone and soft-tissue regeneration, and a range of prosthetic products used by dentists and dental laboratories to restore oral function and aesthetics.

In addition to implant and biomaterial product lines, Straumann provides digital dentistry solutions that support treatment planning and workflows.